Herpes Zoster Ophthalmicus is a diseases which activates itself due to the reoccurrence of varicella zoster virus infection. The disease involves eye and damages the eye and its surrounding structures due to inflammation of nerves.
This report contains market size and forecasts of Herpes Zoster Ophthalmicus Drug in Global, including the following market information:
Global Herpes Zoster Ophthalmicus Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Herpes Zoster Ophthalmicus Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Herpes Zoster Ophthalmicus Drug include Abbott, Novartis, GlaxoSmithKline, Fresenius, SteriMax, Cadila Pharmaceuticals, Shermco, TEVA and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Zoster Ophthalmicus Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Herpes Zoster Ophthalmicus Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Herpes Zoster Ophthalmicus Drug Market Segment Percentages, by Type, 2021 (%)
Oral Drug
Topical Drug
Injectable Drug
Global Herpes Zoster Ophthalmicus Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Herpes Zoster Ophthalmicus Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Herpes Zoster Ophthalmicus Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Herpes Zoster Ophthalmicus Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Herpes Zoster Ophthalmicus Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Herpes Zoster Ophthalmicus Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Novartis
GlaxoSmithKline
Fresenius
SteriMax
Cadila Pharmaceuticals
Shermco
TEVA
Cipla
Mylan
Foamix
Merck